Apollo Hospitals Enterprise Ltd (APOLLOHOSP) is currently trading at 8,770.25 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Apollo Hospitals Enterprise Ltd is a pan‑India integrated healthcare provider operating hospitals, diagnostics, primary care clinics, an omni‑channel pharmacy distribution network and a large digital healthcare platform, with a consolidated network that includes 76 hospitals, ~10,325 capacity beds and material subsidiaries Apollo HealthCo and AHLL delivering out‑of‑hospital care and retail diagnostics. Q3 FY26 consolidated revenues grew 17% year‑on‑year to ₹64,774 million with EBITDA up 27% to ₹9,653 million and PAT up 35% to ₹5,023 million, driven by 14% healthcare services growth, 20% HealthCo revenue growth and AHLL diagnostics expansion; digital losses narrowed significantly and HealthCo cash profit doubled versus prior year. Apollo is pursuing an aggressive capacity build and M&A agenda: a ~₹8,200 crore bed expansion pipeline to add ~4,444 beds over FY26–FY30, plus a composite scheme to spin and list the combined HealthCo/Keimed entity as NewCo, an initiative that reconfigures ownership and aims to unlock value through listing by Q4 FY27. Digital and platform businesses are scaling: Apollo 24|7 reports ~46 million registered users and ~9.5 lakh daily active users, platform GMV grew ~28% in Q3 FY26, Apollo Pharmacy operates 7,113 stores, and Apollo is integrating AI, telehealth and insurance solutions to increase omni‑channel customer journeys and diagnostic/pharmacy penetration across India.

Over the past 52 weeks, Apollo Hospitals Enterprise Ltd has traded between a low of ₹6,680.00 and a high of ₹9,326.80. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Apollo Hospitals Enterprise Ltd has a market capitalization of approximately 1,26,102.74. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Apollo Hospitals Enterprise Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 58.06 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 1,26,102.74 Cr, Apollo Hospitals Enterprise Ltd is classified as a Large Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Apollo Hospitals Enterprise Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Apollo Hospitals Enterprise Ltd is 58.06. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Apollo Hospitals reported Q1 FY27 consolidated revenue of ₹7,044 crore and consolidated net profit of ₹610 crore, versus ₹5,842 crore and ₹441 crore in Q1 FY26.

Market snapshots in the feed showed Apollo Hospitals around Rs 8,888.50 to Rs 8,892.30 on July 6, 2026, roughly 0.06% lower in some updates.

Apollo Hospitals Enterprise entered the Nifty 50, replacing Indian Oil Corporation (IOC), effective March 31, 2022 (close of March 30, 2022).

The meetings were convened under NCLT Chennai directions to consider and approve a composite scheme of arrangement involving Apollo Hospitals, Apollo Healthco, Keimed, and Apollo Healthtech.